A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D.
Int J Dermatol. 1982 Mar;21(2):75-8. doi: 10.1111/j.1365-4362.1982.tb00500.x.
PMID:7068304
Histopathological Features of Riehl Melanosis.
Kim SM, Lee ES, Sohn S, Kim YC.
Am J Dermatopathol. 2020 Feb;42(2):117-121. doi: 10.1097/DAD.0000000000001515.
PMID:31990700
Acquired Dermal Macular Hyperpigmentation: An Update.
Vinay K, Bishnoi A, Kamat D, Chatterjee D, Kumaran MS, Parsad D.
Indian Dermatol Online J. 2021 Aug 2;12(5):663-673. doi: 10.4103/idoj.IDOJ_881_20. eCollection 2021 Sep-Oct.
PMID:34667751
Riehl's Melanosis: A Multimodality, In Vivo, Real-Time Skin Imaging Study with Cellular Resolution Optical Coherence Tomography and Advanced Skin Diagnosis System in a Tertiary Medical Center.
Shen PC, Chan YP, Huang CH, Ng CY.
Bioengineering (Basel). 2022 Aug 26;9(9):419. doi: 10.3390/bioengineering9090419.
PMID:36134965
A novel treatment for Riehl's melanosis targeting both dermal melanin and vessels.